Using fluorescent dye to see tumors during surgery
Part of Cancer clinical trials.
This trial tests whether a fluorescent dye applied to tissue during surgery helps doctors see tumors and check if the tumor removal is complete. If you have a solid tumor and are scheduled for surgery, this study may improve the precision of your operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor confirmed by biopsy
- You are scheduled for surgery at Erasmus Medical Center
- You sign a consent form to participate
- Your surgery is not canceled and a fresh tissue sample is available
- You are not taking part in another trial that gives a different fluorescent dye during surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special camera to look at solid tumors from inside the body during an operation. It tests whether “live” tumor imaging (using a medicine called fluorescein) can be safely performed in people with certain solid cancers.
This trial tests a special dye that helps surgeons see the edges of sarcoma tumors during surgery. It may help them remove all the cancer while saving healthy tissue.
This Phase 2 study tests whether using a fluorescent dye during tumor surgery can help the surgical team better see where the tumor ends. It may help aim for complete removal and lower the chance of the tumor coming back.
This study tests a new injectable dye (NC527-X) that helps surgeons see tumors better during surgery. The dye glows under special light, making it easier to find and remove cancer tissue completely.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
Hear when a new Solid Tumor, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.